TABLE 2

Main features of nonclassic proangiogenic and antiangiogenic factors

Factor Receptors Signaling Pathwaysa Angiogenic Activityb Tumor Growth and Vascularization Interaction with Other Factorsc
In Vitro Assays (ECs) In Vivo Assay (New Vessel Formation)
Differentiation Proliferation Migration Differentiation (Capillary Tube Formation) CAM Rabbit Cornea Sponge Model (Matrigel Plug) Experimental Ischemia
EPO EPO-RA, EPO-RB + PI3K/Akt + JAK/STAT S S S S = = S S ↑ ET-1
ANG-II AT1-R, AT2-R + NOS/NO ? =S SI S= S= S I SI SI S [I], [S]d S (?)= ↑ VEGF
ET ETA-R, ETB-R + BKca + PGE2/COX I S S S S = S = S ↑ VEGF
AM AM1-R, AM2-R + AC + Akt + MAPK I S [N] S S S = = S S ↑ VEGF (?)
PAMP ? ? = = = S = = S = S ↑ VEGF/FGF-2/↑ PDGF (?)
Urotensin-II UT-R ? = N = S S = = = S(?) ?
Leptin Ob-Ra, Ob-Rb + MAPK + STAT-3 = S = = S S = = = ↑ angiopoietin-2↑ VEGF (?)
Adiponectin AdipoR1, AdipoR2 + AMP kinase I [I] [I] = [I] S[I] S S S(?) ↑ FGF-2 (?)
Resistin ? + PI3K + MAPK = S S = = = = = ↑ VEGF
NPY Y1-R/Y2-R (Y5-R) + MAPK = S S S = = S S ?
VIP (PACAP) VPAC1-R + PKA + PI3K + MAPK = = = = = = S = = ↑ VEGF
Substance-P NK1-R + PLC/PKC + NOS/NO = S S = = S S = = ?
Somatostatin sst-2R, sst-3R (sst-1R/sst-5R) - MAPK - NOS/NO = I = = = = = = I ↓ VEGF
Ghrelin GHS-R1a - MAPK - PI3K/Akt S I = I I = = = = ?
Natriuretic peptides A-R/C-R (B-R) - MAPK - JNK = I I I = = = = = ↓ VEGF
  • BKca, Ca2+-activated large conductance potassium channel; COX, cyclooxygenase; AC, adenylate cyclase; JNK, cJun N-terminal kinase

  • a >+, stimulation; -, inhibition

  • b I, inhibition; N, no effect; S, stimulation; =, no findings available

  • c ↑, up-regulation; ↓, down-regulation

  • d Brackets indicate unorthodox findings